Chinese prescription Kangen-karyu attenuates neuronal damage and improves cognitive function in global cerebral ischemia/reperfusion by regulating ROS-mediated MAPK activation.

Saved in:
Bibliographic Details
Title: Chinese prescription Kangen-karyu attenuates neuronal damage and improves cognitive function in global cerebral ischemia/reperfusion by regulating ROS-mediated MAPK activation.
Authors: Lee JH; Institute of New Frontier Research Team, Research Institute of Medical-Bio Convergence, Hallym University, Chuncheon, Republic of Korea., Kim JT; Institute of New Frontier Research Team, Research Institute of Medical-Bio Convergence, Hallym University, Chuncheon, Republic of Korea., Han SW; Institute of New Frontier Research Team, Research Institute of Medical-Bio Convergence, Hallym University, Chuncheon, Republic of Korea., Pak S; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea., Lee S; Institute of New Frontier Research Team, Research Institute of Medical-Bio Convergence, Hallym University, Chuncheon, Republic of Korea., Cho Y; Institute of New Frontier Research Team, Research Institute of Medical-Bio Convergence, Hallym University, Chuncheon, Republic of Korea., Akimoto Y; Iskra Industry Co., Ltd., Chuo, Japan., Shoji M; Pharmacy of Kaikido, Yokohama, Japan., Zhang L; Iskra Industry Co., Ltd., Chuo, Japan., Song K; Bio and Health Photonics Research Center Korea Photonics Technology Institute, Cheonan, Republic of Korea., Choi HR; Bio and Health Photonics Research Center Korea Photonics Technology Institute, Cheonan, Republic of Korea., Han GS; Life Genomics Co., Ltd., Ressearch and Development Center, Suwon, Republic of Korea., Chung HY; Department of Pharmacy, College of Pharmacy, Pusan National University, Busan, Republic of Korea., Choi JS; Department of Food Science and Human Nutrition, Chongbuk National University, Jeonju, Republic of Korea., Lim JD; Department of Bio-Health Convergence, Kangwon National University, Chuncheon, Republic of Korea.; Convergence Program of Bio-pharmaceutical Engineering, Kangwon National University, Chuncheon, Republic of Korea., Jeon JP; Department of Neurosurgery, College of Medicine, Hallym University, Chuncheon, Republic of Korea., Park CH; Institute of New Frontier Research Team, Research Institute of Medical-Bio Convergence, Hallym University, Chuncheon, Republic of Korea.; Convergence Program of Bio-pharmaceutical Engineering, Kangwon National University, Chuncheon, Republic of Korea., Youn DH; Institute of New Frontier Research Team, Research Institute of Medical-Bio Convergence, Hallym University, Chuncheon, Republic of Korea.
Source: Frontiers in pharmacology [Front Pharmacol] 2026 Jul 08; Vol. 17, pp. 1860305. Date of Electronic Publication: 2026 Jul 08 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1663-9812
DOI:10.3389/fphar.2026.1860305